About Steve I graduated with a B.S. cum laude in Pharmacy from Butler University, after which I earned a Ph.D. in Pharmacology from Vanderbilt University in the laboratory of Michael Tamkun. As a postdoctoral fellow at the University of Iowa in the laboratory of Kevin Campbell, I identified the alpha-sarcoglycan gene and identified mutations that cause the LGMD2D form of muscular dystrophy. In 1995 I joined the Upjohn Company, which soon became part of Pharmacia and, later, Pfizer. During the next 12 years, I applied multiple technologies to identify and validate new molecular targets for treatment of airway inflammation (1995-1997), pain and CNS diseases (1998-2003), and cardiovascular diseases (2003-2007), and moved targets through early project stages through lead development. Currently, as a scientist within Pfizer's Indications Discovery Unit, I strive to discover novel uses for compounds in Pfizer’s development portfolio to treat CNS diseases including psychosis and Alzheimer's disease.

Steve's Gallery No Photos Uploaded Yet!Click here to see all of Steve's photos.

Steve's Friendlist

Steve hasn't added any friends yet.

Click here to see Steve's entire friendlist